Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy

Author(s): Feng Yang, Zhi-Yi Chen, Yan Lin

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 8 , 2013

Become EABM
Become Reviewer
Call for Editor


In recent years, targeted ultrasound contrast agents (UCA) have emerged with the rapid development of contrast-enhanced ultrasound technology and bio-nanotechnology, showing good prospects for applications in molecular imaging and targeted therapy. The non-invasive treatment modality can reduce the drug dosage, toxicity and side effects, providing a new kind of methodology and approach for treatments, which will greatly expand the research and its applications. Targeted UCA have been developed rapidly in recent years, and a variety of new UCA appear, such as multi-functional UCA, multi-modal UCA, UCA with double ligands or more ligands, long-circulating UCA and immune type UCA, which meet growing clinical and research needs. The novel UCA have made a great progress and play an increasingly important role in molecular imaging. In this article, we reviewed the concepts of ultrasound molecular imaging, and summarized the applications of targeted UCA in molecular imaging and targeted therapy.

Keywords: Contrast agent, microbubble, targeted, molecular imaging, diagnosis, therapy, ultrasound contrast agents (UCA), drug dosage

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 03 January, 2013
Page: [1516 - 1527]
Pages: 12
DOI: 10.2174/1381612811319080019
Price: $65

Article Metrics

PDF: 29